J. C. Jennette, R. J. Falk, P. A. Bacon, N. Basu, M. C. Cid et al., Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides, vol.65, pp.1-11, 2012.

W. Heberden, Commentarii di morborium-historia et curatione. London: Payne, 1802.

J. L. Schönlein, Allgemeine undspecielle pathologie undtherapie

E. Henoch and . Neunter-absschnitt, Die hämorrhagische. Diathese purpura, Berlin:Hirschwald, 1899.

J. A. Stevenson, L. A. Leong, A. H. Cohen, and W. A. Border, Henoch-Schönlein purpura : simultaneous demonstration of IgA deposits in involved skin, intestine, and kidney, Arch Pathol Lab Med, issue.106, pp.192-197, 1982.

H. J. Oh, S. V. Ahn, D. E. Yoo, S. J. Kim, D. H. Shin et al., Clinical outcomes, when matched at presentation, do not vary between adult-onset Henöch-Schönlein purpura nephritis and IgA nephropathy, Kidney Int. déc, vol.82, issue.12, pp.1304-1316, 2012.

M. Piram and A. Mahr, Epidemiology of immunoglobulin A vasculitis (Henoch-Schönlein): current state of knowledge, Curr Opin Rheumatol. mars, vol.25, issue.2, pp.171-179, 2013.

R. A. Watts, S. Lane, and D. Scott, What is known about the epidemiology of the vasculitides?, Best Pract Res Clin Rheumatol. avr, vol.19, issue.2, pp.191-207, 2005.

F. T. Saulsbury, Epidemiology of Henoch-Schönlein purpura, Cleve Clin J Med, vol.69, issue.2, pp.87-89, 2002.

Y. Yang, C. Hung, C. Hsu, L. Wang, Y. Chuang et al., A nationwide survey on epidemiological characteristics of childhood Henoch-Schönlein purpura in Taiwan, Rheumatology. 1 mai, vol.44, issue.5, pp.618-640, 2005.

J. Aalberse, K. Dolman, G. Ramnath, R. R. Pereira, and J. Davin, Henoch Schonlein purpura in children: an epidemiological study among Dutch paediatricians on incidence and diagnostic criteria, Ann Rheum Dis. 1 déc, vol.66, issue.12, pp.1648-50, 2007.

P. Dolezalová, P. Telekesová, D. Nemcová, and J. Hoza, Incidence of vasculitis in children in the Czech Republic: 2-year prospective epidemiology survey, J Rheumatol, vol.31, issue.11, pp.2295-2304, 2004.

M. Piram, C. Maldini, S. Biscardi, N. De-suremain, C. Orzechowski et al., Incidence of IgA vasculitis in children estimated by four-source capture-recapture analysis: a population-based study, Rheumatology. août, vol.56, issue.8, pp.1358-66, 2017.

S. Trapani, A. Micheli, F. Grisolia, M. Resti, E. Chiappini et al., Henoch Schonlein Purpura in Childhood: Epidemiological and Clinical Analysis of 150 Cases Over a 5-year Period and Review of Literature, Semin Arthritis Rheum. déc, vol.35, issue.3, pp.143-53, 2005.

M. C. Calvino, J. Llorca, C. García-porrua, J. L. Fernandez-iglesias, P. Rodriguez-ledo et al., Henoch-Schönlein purpura in children from northwestern Spain: a 20-year epidemiologic and clinical study, Medicine (Baltimore), vol.80, issue.5, pp.279-290, 2001.

A. Ho?evar, Z. Rotar, J. Ostrovr?nik, V. Jur?i?, A. Vizjak et al., Incidence of IgA vasculitis in the adult Slovenian population, Br J Dermatol. sept, vol.171, issue.3, pp.524-531, 2014.

Y. Kang, J. Park, Y. Ha, M. Kang, H. Park et al., Differences in Clinical Manifestations and Outcomes between Adult and Child Patients with Henoch-Schönlein Purpura, J Korean Med Sci, vol.29, issue.2, p.198, 2014.

V. Calvo-río, J. Loricera, C. Mata, L. Martín, F. Ortiz-sanjuán et al., Henoch-Schönlein Purpura in Northern Spain: Clinical Spectrum of the Disease in 417 Patients From a Single Center, Medicine (Baltimore). mars, vol.93, issue.2, pp.106-119, 2014.

J. M. Gardner-medwin, P. Dolezalova, C. Cummins, and T. R. Southwood, Incidence of Henoch-Schonlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. The Lancet, vol.360, pp.1197-202, 2002.

S. R. Atkinson and D. J. Barker, Seasonal distribution of Henoch-Schönlein purpura, Br J Prev Soc Med, vol.30, p.22, 1976.

M. Levy, M. Broyer, A. Arsan, D. Levy-bentolila, and R. Habib, Anaphylactoid purpura nephritis in childhood: natural history and immunopathology, Adv Nephrol Necker Hosp, vol.6, pp.183-228, 1976.

S. Hung, Y. , Y. Lin, Y. Wang, L. Lee et al., Clinical Manifestations and Outcomes of Henoch-Schönlein Purpura: Comparison between Adults and Children, Pediatr Neonatol. août, vol.50, issue.4, pp.162-170, 2009.

E. Batu, A. Sar?, A. Erden, H. Sönmez, B. Arma?an et al., Comparing immunoglobulin A vasculitis (Henoch-Schönlein purpura) in children and adults: a single-centre study from Turkey, Scand J Rheumatol, vol.47, issue.6, pp.481-487, 2018.

J. M. Zurada, K. M. Ward, and M. E. Grossman, Henoch-Schönlein purpura associated with malignancy in adults, J Am Acad Dermatol, vol.55, issue.5, pp.65-70, 2006.

O. Fain, M. Hamidou, P. Cacoub, B. Godeau, B. Wechsler et al., Vasculitides associated with malignancies: Analysis of sixty patients, Arthritis Rheum. 15 déc, vol.57, issue.8, pp.1473-80, 2007.

E. Pertuiset, F. Lioté, E. Launay-russ, F. Kemiche, I. Cerf-payrastre et al., Adult Henoch-Schönlein purpura associated with malignancy, Seminars in arthritis and rheumatism, pp.360-367, 2000.

J. Podjasek, D. Wetter, M. Pittelkow, and D. Wada, Henoch-Schönlein Purpura Associated With Solid-organ Malignancies: Three Case Reports and a Literature Review, Acta Derm Venereol, vol.92, issue.4, pp.388-92, 2012.

A. Flynn, B. Du-prey, A. Ardati, H. Raman, M. Lemaire et al., Adult-onset malignancy-associated Henoch-Schönlein purpura, Scand J Rheumatol. août, vol.40, issue.4, pp.325-331, 2011.

A. Angelier, L. Petit, A. Wynckel, V. Vuiblet, P. Birembaut et al., Purpura rhumatoïde révélateur d'un carcinome épidermoïde bronchique, Rev Mal Respir. mars, vol.28, issue.3, pp.372-378, 2011.

M. Frigui, M. Kechaou, B. Hmida, M. Kamoun, K. Khanfir et al., Association purpura rhumatoïde de l'adulte et carcinome épidermoïde du poumon, Néphrologie Thérapeutique. juin, vol.5, issue.3, pp.201-205, 2009.

L. Couzi, J. Cluzeau, S. Skopinski, J. Constans, and C. Conri, Purpura rhumatoïde et cancer de la prostate, Rev Médecine Interne, vol.23, issue.8, pp.717-719, 2002.

V. A. Garcias and H. W. Herr, Henoch-Schonlein purpura associated with cancer of prostate, Urology, vol.19, issue.2, pp.155-158, 1982.

Y. H. Hong, Renal cell carcinoma presenting as Henoch-Schönlein purpura with leukocytoclastic vasculitis, hematuria, proteinuria and abdominal pain, Rheumatol Int. août, vol.30, issue.10, pp.1373-1379, 2010.

S. Ota, T. Haruyama, M. Ishihara, M. Natsume, Y. Fukasawa et al., Paraneoplastic IgA Vasculitis in an Adult with Lung Adenocarcinoma, Intern Med. 1 mai, vol.57, issue.9, pp.1273-1279, 2018.

T. Pankhurst, Malignancy is increased in ANCA-associated vasculitis, Rheumatology. 13 juill, vol.43, issue.12, pp.1532-1537, 2004.

E. Pillebout, E. Thervet, G. Hill, C. Alberti, P. Vanhille et al., Henoch-Schonlein Purpura in Adults: Outcome and Prognostic Factors, J Am Soc Nephrol. 1 mai, vol.13, issue.5, pp.1271-1279, 2002.

J. M. Woof and M. A. Kerr, IgA function -variations on a theme, Immunology, vol.113, issue.2, pp.175-182, 2004.

E. Pillebout and J. Vérine, Glomérulonéphrite à dépôts mésangiaux d'immunoglobulines A, Nephrol Ther, vol.12, issue.4, pp.238-254, 2016.

M. Pohl, Henoch-Schönlein purpura nephritis, Pediatr Nephrol. févr, vol.30, issue.2, pp.245-52, 2015.

J. Berger, H. Yaneva, B. Nabarra, and C. Barbanel, Recurrence of mesangial deposition of IgA after renal transplantation, Kidney Int. avr, vol.7, issue.4, pp.232-273, 1975.

C. Ponticelli, L. Traversi, A. Feliciani, B. M. Cesana, G. Banfi et al., Kidney transplantation in patients with IgA mesangial glomerulonephritis, Kidney Int, vol.60, issue.5, pp.1948-54, 2001.

S. Ji, M. Liu, J. Chen, L. Yin, G. Sha et al., The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation, Clin Transplant, vol.18, issue.5, pp.536-576, 2004.

R. C. Monteiro, L. Halbwachs-mecarelli, M. C. Roque-barreira, L. H. Noel, J. Berger et al., Charge and size of mesangial IgA in IgA nephropathy, Kidney Int, vol.28, issue.4, pp.666-71, 1985.

R. J. Wyatt, The complement system in IgA nephropathy and Henoch-Schönlein purpura: functional and genetic aspects, Contrib Nephrol, vol.104, pp.82-91, 1993.

A. C. Allen, E. M. Bailey, P. Brenchley, K. S. Buck, J. Barratt et al., Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients, Kidney Int. sept, vol.60, issue.3, pp.969-73, 2001.

T. Kokubo, Y. Hiki, H. Iwase, A. Tanaka, K. Toma et al., Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins, J Am Soc Nephrol JASN. nov, vol.9, issue.11, pp.2048-54, 1998.

M. Tomana, J. Novak, B. A. Julian, K. Matousovic, K. Konecny et al., Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies, J Clin Invest. 1 juill, vol.104, issue.1, pp.73-81, 1999.

J. Novak, B. A. Julian, M. Tomana, and J. Mesteck, Progress in molecular and genetic studies of IgA nephropathy, J Clin Immunol. sept, vol.21, issue.5, pp.310-337, 2001.

A. C. Allen, P. S. Topham, S. J. Harper, and J. Feehally, Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc. avr, vol.12, issue.4, pp.701-707, 1997.

J. Davin and R. Coppo, Henoch-Schönlein purpura nephritis in children, Nat Rev Nephrol. oct, vol.10, issue.10, pp.563-73, 2014.

R. C. Monteiro and J. Van-de-winkel, IgA Fc receptors, Annu Rev Immunol, vol.21, pp.177-204, 2003.

E. Haddad, I. C. Moura, M. Arcos-fajardo, M. Macher, V. Baudouin et al., Enhanced expression of the CD71 mesangial IgA1 receptor in Berger disease and Henoch-Schönlein nephritis: association between CD71 expression and IgA deposits, J Am Soc Nephrol JASN. févr, vol.14, issue.2, pp.327-364, 2003.

T. Robert, L. Berthelot, A. Cambier, E. Rondeau, and R. C. Monteiro, Molecular Insights into the Pathogenesis of IgA Nephropathy, Trends Mol Med. déc, vol.21, issue.12, pp.762-75, 2015.

R. C. Monteiro, Role of IgA and IgA fc receptors in inflammation, J Clin Immunol. janv, vol.30, issue.1, pp.1-9, 2010.

J. K. Boyd and J. Barratt, Immune complex formation in IgA nephropathy: CD89 a « saint » or a « sinner, Kidney Int. déc, vol.78, issue.12, pp.1211-1214, 2010.

S. M. Lechner, C. Papista, J. M. Chemouny, L. Berthelot, and R. C. Monteiro, Role of IgA receptors in the pathogenesis of IgA nephropathy, J Nephrol. févr, vol.29, issue.1, pp.5-11, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02445659

M. M. Amoli, W. Thomson, A. H. Hajeer, M. C. Calviño, C. Garcia-porrua et al., HLA-DRB1*01 association with Henoch-Schönlein purpura in patients from northwest Spain, J Rheumatol. juin, vol.28, issue.6, pp.1266-70, 2001.

R. López-mejías, F. Genre, B. S. Pérez, S. Castañeda, N. Ortego-centeno et al., Brief Report: Association of HLA-DRB1*01 With IgA Vasculitis (Henoch-Schönlein): HLA-DRB1*01 AND IgAV, Arthritis Rheumatol. mars, vol.67, issue.3, pp.823-830, 2015.

M. M. Amoli, W. Thomson, A. H. Hajeer, M. C. Calviño, C. Garcia-porrua et al., HLA-B35 association with nephritis in Henoch-Schönlein purpura, J Rheumatol. mai, vol.29, issue.5, pp.948-957, 2002.

D. K. Jin, T. Kohsaka, J. W. Koo, I. S. Ha, H. I. Cheong et al., Complement 4 Locus II Gene Deletion and DQA1*0301 Gene: Genetic Risk Factors for IgA Nephropathy and Henoch-Schönlein Nephritis, Nephron, vol.73, issue.3, pp.390-395, 1996.

V. Stefansson-thors, R. Kolka, S. L. Sigurdardottir, E. Vo, G. Arason et al., Increased Frequency of C4B*Q0 Alleles in Patients with Henoch-Schonlein Purpura, Scand J Immunol. mars, vol.61, issue.3, pp.274-282, 2005.

Y. Yang, H. Lai, C. Kao, Y. Lin, and B. Chiang, The association between transforming growth factor-B gene promoter C-509T polymorphism and Chinese children with Henoch-Schonlein purpura, Pediatr Nephrol, 2004.

J. Wang, Y. Shi, Y. Huang, C. Wu, and X. Li, Association of tumor necrosis factor-alpha gene polymorphisms with Henoch-Schonlein purpura nephritis in children, Zhongguo Dang Dai Er Ke Za Zhi Chin J Contemp Pediatr. févr, vol.15, issue.2, pp.88-90, 2013.

G. Ding, C. Wang, C. Guan, W. Yuan, Y. Su et al., Heat shock protein 70-2 and tumor necrosis factor-? gene polymorphisms in Chinese children with Henoch-Schönlein purpura, World J Pediatr. févr, vol.12, issue.1, pp.49-54, 2016.

M. M. Amoli, M. C. Calviño, C. Garcia-porrua, J. Llorca, W. Ollier et al., Interleukin 1beta gene polymorphism association with severe renal manifestations and renal sequelae in Henoch-Schönlein purpura, J Rheumatol. févr, vol.31, issue.2, pp.295-303, 2004.

R. López-mejías, F. Genre, S. Remuzgo-martínez, S. Pérez, B. Castañeda et al., Interleukin 1 beta (IL1ß) rs16944 genetic variant as a genetic marker of severe renal manifestations and renal sequelae in Henoch-Schönlein purpura, Clin Exp Rheumatol. juin, vol.34, issue.3, pp.84-88, 2016.

M. M. Amoli, W. Thomson, A. H. Hajeer, M. C. Calviño, C. Garcia-porrua et al., Interleukin 1 receptor antagonist gene polymorphism is associated with severe renal involvement and renal sequelae in Henoch-Schönlein purpura, J Rheumatol. juill, vol.29, issue.7, pp.1404-1411, 2002.

Z. H. Liu, Z. H. Cheng, Y. S. Yu, Z. Tang, and L. S. Li, Interleukin-1 receptor antagonist allele: is it a genetic link between Henoch-Schönlein nephritis and IgA nephropathy?, Kidney Int. juin, vol.51, issue.6, pp.1938-1980, 1997.

O. Torres, R. Palomino-morales, J. A. Miranda-filloy, T. R. Vazquez-rodriguez, J. Martin et al., IL-18 gene polymorphisms in Henoch-Schönlein purpura, Clin Exp Rheumatol. févr, vol.28, issue.1, p.114, 2010.

M. M. Amoli, J. Martin, J. A. Miranda-filloy, C. Garcia-porrua, W. E. Ollier et al., Lack of association between interleukin-6 promoter polymorphism at position-174 and Henoch-Schönlein purpura, Clin Exp Rheumatol, vol.25, issue.1, pp.6-9, 2007.

R. López-mejías, S. Pérez, B. Genre, F. Castañeda, S. Ortego-centeno et al., No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and Henoch-Schönlein purpura: IL6R and IL6ST and Henoch-Schönlein purpura, Tissue Antigens. déc, vol.82, issue.6, pp.416-425, 2013.

R. López-mejías, S. Pérez, B. Genre, F. Castañeda, S. Ortego-centeno et al., Lack of association between IL6 gene and Henoch-Schönlein purpura, Clin Exp Rheumatol. juin, vol.32, issue.3, pp.141-142, 2014.

H. Xu, W. Li, H. Fu, and G. Jiang, Interferon-gamma gene polymorphism +874 (a/t) in Chinese children with Henoch-Schonlein purpura, Iran J Allergy Asthma Immunol. juin, vol.13, issue.3, pp.184-193, 2014.

R. Gershoni-baruch, Y. Broza, and R. Brik, Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura, J Pediatr, vol.143, issue.5, pp.658-61, 2003.

Z. B. Ozçakar, F. Yalçinkaya, N. Cakar, B. Acar, O. Kasapçopur et al., MEFV mutations modify the clinical presentation of Henoch-Schönlein purpura, J Rheumatol. déc, vol.35, issue.12, pp.2427-2436, 2008.

Y. H. Park, G. Wood, D. L. Kastner, and J. J. Chae, Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS, Nat Immunol. août, vol.17, issue.8, pp.914-935, 2016.

S. Georgin-lavialle, V. Hentgen, S. Stojanovic, K. Bachmeyer, C. Rodrigues et al., La fièvre méditerranéenne familiale, Rev Médecine Interne. avr, vol.39, issue.4, pp.240-55, 2018.

D. Carvalho, M. Adotévi, O. Frenkel, V. Thibault, G. et al., Immunité adaptative : activation et polarisation des lymphocytes T

A. Siri, H. De-boysson, and G. Boursier, Actualité sur les lymphocytes T régulateurs CD4 +. médecine/sciences, juin, vol.28, issue.6-7, pp.646-51, 2012.

M. Essakalli, C. Brick, N. Bennani, N. Benseffaj, S. Ouadghiri et al., Le lymphocyte TH17 dernier-né de la famille des lymphocytes T CD4+, Pathol Biol. déc, vol.58, issue.6, pp.437-480, 2010.

O. Chen, X. Zhu, H. Ren, Y. Wang, and R. Sun, The imbalance of Th17/Treg in Chinese children with Henoch-Schonlein purpura, Int Immunopharmacol. mai, vol.16, issue.1, pp.67-71, 2013.

Y. Li, C. Li, G. Wang, J. Yang, and Y. Zu, Investigation of the change in CD4 + T cell subset in children with Henoch-Schonlein purpura, Rheumatol Int. déc, vol.32, issue.12, pp.3785-92, 2012.

H. Jen, Y. Chuang, S. Lin, B. Chiang, Y. et al., Increased serum interleukin-17 and peripheral Th17 cells in children with acute Henoch-Schönlein purpura, Pediatr Allergy Immunol Off Publ Eur Soc Pediatr Allergy Immunol. déc, vol.22, issue.8, pp.862-870, 2011.

B. Gülhan, D. Orhan, G. Kale, N. Besbas, and S. Özen, Studying cytokines of T helper cells in the kidney disease of IgA vasculitis (Henoch-Schönlein purpura), Pediatr Nephrol. août, vol.30, issue.8, pp.1269-77, 2015.

J. Turner, H. Paust, O. M. Steinmetz, and U. Panzer, The Th17 immune response in renal inflammation, Kidney Int. juin, vol.77, issue.12, pp.1070-1075, 2010.

M. U. Yazici, D. Orhan, G. Kale, N. Besbas, and S. Ozen, Studying IFN-gamma, IL-17 and FOXP3 in pediatric lupus nephritis, Pediatr Nephrol Berl Ger. mai, vol.29, issue.5, pp.853-62, 2014.

J. K. Boyd, C. K. Cheung, K. Molyneux, J. Feehally, and J. Barratt, An update on the pathogenesis and treatment of IgA nephropathy, Kidney Int. mai, vol.81, issue.9, pp.833-876, 2012.

Y. Pan, Q. Ye, W. Shao, S. Shang, J. Mao et al., Relationship between immune parameters and organ involvement in children with Henoch-Schonlein purpura, PloS One, vol.9, issue.12, p.115261, 2014.

A. Audemard-verger, E. Pillebout, A. Jamin, L. Berthelot, C. Aufray et al., Recruitment of CXCR3+ T cells into injured tissues in adult IgA vasculitis patients correlates with disease activity, J Autoimmun, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02345042

A. Binard and A. Saraux, Inflammation rhumatismale. EMC -Appar Locomoteur, janv, vol.1, issue.1, pp.1-20, 2006.

N. Besbas, U. Saatci, S. Ruacan, S. Ozen, A. Sungur et al., The role of cytokines in Henoch Schonlein purpura, Scand J Rheumatol, vol.26, issue.6, pp.456-60, 1997.

Y. H. Yang, H. J. Lai, C. M. Huang, L. C. Wang, Y. T. Lin et al., Sera from children with active Henoch-Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells, Ann Rheum Dis, vol.63, issue.11, pp.1511-1514, 2004.

T. H. Wu, S. C. Wu, T. P. Huang, C. L. Yu, and C. Y. Tsai, Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura, Nephron, vol.74, issue.1, pp.79-88, 1996.

C. Lin, Y. , Y. Lee, C. Huang, C. Wang et al., Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura, J Microbiol Immunol Infect Wei Mian Yu Gan Ran Za Zhi. déc, vol.39, issue.6, pp.476-82, 2006.

Y. Yang, Y. Chuang, L. Wang, H. Huang, M. E. Gershwin et al., The immunobiology of Henoch-Schönlein purpura, Autoimmun Rev. janv, vol.7, issue.3, pp.179-84, 2008.

T. Chen, R. Jia, Z. Guo, N. Cao, M. Li et al., Elevated serum interleukin-33 levels in patients with Henoch-Schönlein purpura, Arch Dermatol Res. mars, vol.305, issue.2, pp.173-180, 2013.

G. Rostoker, J. C. Rymer, G. Bagnard, M. Petit-phar, M. Griuncelli et al., Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schönlein purpura nephritis, and a potential target of immunoglobulin therapy?, Clin Exp Immunol. déc, vol.114, issue.3, pp.468-76, 1998.

T. M. Carlos and J. M. Harlan, Leukocyte-endothelial adhesion molecules, Blood, vol.84, issue.7, pp.2068-101, 1994.

S. Kimura, S. Takeuchi, Y. Soma, and T. Kawakami, Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Schönlein purpura, Clin Exp Dermatol, vol.38, issue.7, pp.730-736, 2013.

E. Pillebout, A. Jamin, H. Ayari, P. Housset, M. Pierre et al., Biomarkers of IgA vasculitis nephritis in children, PloS One, vol.12, issue.11, p.188718, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-02154824

L. Berthelot, A. Jamin, D. Viglietti, J. M. Chemouny, H. Ayari et al., Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort, Nephrol Dial Transplant, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02445650

T. Kuret, K. Lakota, P. ?igon, M. Ogri?, S. Sodin-?emrl et al., Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis, Clin Rheumatol. févr, vol.38, issue.2, pp.331-339, 2019.

L. Wu, L. Yuan, W. Fei, F. Deng, Q. Zhang et al., Impact of sera from children with active Henoch-Schönlein purpura on human umbilical venous endothelial cells (HUVECs) and protective effects of methylprednisolone against HUVECs injury, Zhongguo Dang Dai Er Ke Za Zhi Chin J Contemp Pediatr. janv, vol.14, issue.1, pp.59-63, 2012.

Y. Yang, Y. Huang, Y. Lin, L. Wang, Y. Chuang et al., Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway, Clin Exp Immunol. mai, vol.144, issue.2, pp.247-53, 2006.

K. Harada, Y. Akai, N. Kurumatani, M. Iwano, and Y. Saito, Prognostic value of urinary interleukin 6 in patients with IgA nephropathy: an 8-year follow-up study, Nephron. déc, vol.92, issue.4, pp.824-830, 2002.

J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy et al., IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines, Immunity, vol.23, issue.5, pp.479-90, 2005.

Z. Yang, Y. Liang, W. Xi, C. Li, and R. Zhong, Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population, Clin Exp Med. juin, vol.11, issue.2, pp.75-80, 2011.

Y. Choi, H. Choi, M. Pyun, B. Maeng, Y. Park et al., Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production, vol.114, pp.3117-3143, 2009.

S. Demyanets, V. Konya, S. P. Kastl, C. Kaun, S. Rauscher et al., Interleukin-33 induces expression of adhesion molecules and inflammatory activation in human endothelial cells and in human atherosclerotic plaques, Arterioscler Thromb Vasc Biol. sept, vol.31, issue.9, pp.2080-2089, 2011.

D. Carlo, P. Rosa, A. Maria, P. Laura, A. Gabriella et al., Cytokine Pattern and Endothelium Damage Markers in Henoch-Schönlein Purpura, Immunopharmacol Immunotoxicol. sept, vol.30, issue.3, pp.623-632, 2008.

M. Gattorno, S. Vignola, G. Barbano, M. P. Sormani, F. Sabatini et al., Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus, J Rheumatol. sept, vol.27, issue.9, pp.2251-2256, 2000.

F. Gok, Y. Ugur, S. Ozen, and A. Dagdeviren, Pathogenesis-related adhesion molecules in Henoch-Schonlein vasculitis, Rheumatol Int. févr, vol.28, issue.4, pp.313-319, 2008.

T. Chen, Z. Guo, M. Li, J. Li, X. Jiao et al., Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura: TWEAK in Henoch-Schonlein purpura, Clin Exp Immunol, vol.166, issue.1, pp.64-71, 2011.

W. Xu, Y. Zhao, and Y. Liu, Role of the TWEAK/Fn14 pathway in autoimmune diseases, Immunol Res. févr, vol.64, issue.1, pp.44-50, 2016.

J. A. Mills, B. A. Michel, D. A. Bloch, L. H. Calabrese, G. G. Hunder et al., The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura, Arthritis Rheum. août, vol.33, issue.8, pp.1114-1135, 1990.

L. H. Calabrese, B. A. Michel, D. A. Bloch, W. P. Arend, S. M. Edworthy et al., The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculitis, Arthritis Rheum. août, vol.33, issue.8, pp.1108-1121, 1990.

S. D. Helander, D. Castro, F. R. Gibson, and L. E. , Henoch-Schönlein purpura: clinicopathologic correlation of cutaneous vascular IgA deposits and the relationship to leukocytoclastic vasculitis, Acta Derm Venereol. mars, vol.75, issue.2, pp.125-134, 1995.

S. Ozen and . Eular/, PReS endorsed consensus criteria for the classification of childhood vasculitides, Ann Rheum Dis, vol.3, issue.7, pp.936-977, 2005.

S. Ozen, A. Pistorio, S. M. Iusan, A. Bakkaloglu, T. Herlin et al., EULAR/PRINTO/PRES criteria for Henoch-Schonlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria, Ann Rheum Dis. 1 mai, vol.69, issue.5, pp.798-806, 2010.

A. Ho?evar, Z. Rotar, V. Jur?i?, J. Pi?em, S. ?u?nik et al., IgA vasculitis in adults: the performance of the EULAR/PRINTO/PRES classification criteria in adults, Disponible sur, vol.18, 2016.

É. Pillebout, D. Nochy, É. Thervet, and . Purpura-rhumatoïde, Néphrologie Thérapeutique. déc, vol.5, issue.7, pp.663-75, 2009.

F. Saulsbury, Hemorrhagic bullous lesions in Henoch-Schonlein purpura, Pediatr Dermatol. sept, vol.15, issue.5, pp.357-366, 1998.

P. É. Verine and J. , Purpura rhumatoïde de l'adulte, Rev Médecine Interne. juin, vol.35, issue.6, pp.372-81, 2014.

H. J. Mccarthy and E. J. Tizard, Clinical practice : Diagnosis and management of Henoch-Schönlein purpura, Eur J Pediatr. juin, vol.169, issue.6, pp.643-50, 2010.

W. Chang, Y. , Y. Lin, Y. Chiang, and B. , Gastrointestinal manifestations in Henoch-Schönlein purpura: a review of 261 patients, Acta Paediatr, vol.93, issue.11, pp.1427-1458, 2004.

M. Kawasaki, K. Hizawa, K. Aoyagi, F. Kuroki, T. Nakahara et al., Ileitis caused by Henoch-Schönlein purpura. An endoscopic view of the terminal ileum, J Clin Gastroenterol. juill, vol.25, issue.1, pp.396-404, 1997.

P. Menon, S. Singh, N. Ahuja, and T. A. Winter, Gastrointestinal Manifestations of Henoch-Schoenlein Purpura, Dig Dis Sci. janv, vol.58, issue.1, pp.42-47, 2013.

S. S. Uppal, M. Hussain, A. , H. A. Nampoory, M. Al-saeid et al., Henoch-Schonlein's purpura in adults versus children/adolescents: A comparative study, Clin Exp Rheumatol, vol.24, issue.2, p.26, 2006.

R. Blanco, V. M. Martínez-taboada, V. Rodríguez-valverde, M. García-fuentes, and G. Ma, Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome, Arthritis Rheum. mai, vol.40, issue.5, pp.859-64, 1997.

C. García-porrúa, M. C. Calviño, J. Llorca, J. M. Couselo, and G. Ma, Henoch-Schönlein purpura in children and adults: Clinical differences in a defined population, Semin Arthritis Rheum. déc, vol.32, issue.3, pp.149-56, 2002.

A. Yong, S. Lee, and Y. Tay, The profile of adult onset Henoch-Schönlein purpura in an Asian population, Int J Dermatol, vol.54, issue.11, pp.1236-1241, 2015.

V. Gupta, A. Aggarwal, R. Gupta, C. Chowdhury, A. Agarwal et al., Differences between adult and pediatric onset Henoch-Schonlein purpura from North India, Int J Rheum Dis, vol.21, issue.1, pp.292-298, 2018.

O. Jauhola, J. Ronkainen, O. Koskimies, M. Ala-houhala, P. Arikoski et al., Renal manifestations of Henoch-Schonlein purpura in a 6-month prospective study of 223 children, Arch Dis Child, vol.95, issue.11, pp.877-82, 2010.

W. Chang, Y. , Y. Wang, L. Lin, Y. Chiang et al., Renal manifestations in Henoch-Schönlein purpura: a 10-year clinical study, Pediatr Nephrol. sept, vol.20, issue.9, pp.1269-72, 2005.

H. Narchi, Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review, Arch Dis Child. 1 sept, vol.90, issue.9, pp.916-936, 2005.

J. M. Heaton, D. R. Turner, and J. S. Cameron, Localization of glomerular ''deposits'' in Henoch-Schonlein nephritis, Histopathology, issue.1, pp.93-104, 1977.

G. Rostoker, Schonlein-Henoch Purpura in Children and Adults: Diagnosis, Pathophysiology and Management, BioDrugs, vol.15, issue.2, pp.99-138, 2001.

C. W. Trygstad and E. R. Stiehm, Elevated serum IgA globulin in anaphylactoid purpura, Pediatrics, vol.47, p.1023, 1971.

J. Davin, T. Berge, I. J. Weening, and J. J. , What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis?, Kidney Int. mars, vol.59, issue.3, pp.823-857, 2001.

Q. Lin, Y. Min, Y. Li, Y. Zhu, X. Song et al., Henoch-Schönlein purpura with hypocomplementemia, Pediatr Nephrol. mai, vol.27, issue.5, pp.801-807, 2012.

V. Calvo-río, J. L. Hernández, F. Ortiz-sanjuán, J. Loricera, N. Palmou-fontana et al., Relapses in patients with Henoch-Schönlein purpura: Analysis of 417 patients from a single center, Medicine (Baltimore). juill, vol.95, issue.28, p.4217, 2016.

J. Ronkainen, M. Nuutinen, and O. Koskimies, The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study, The Lancet. août, vol.360, issue.9334, pp.666-70, 2002.

A. R. Goldstein, R. H. White, R. Akuse, and C. Chantler, Long-term follow-up of childhood Henoch-Schönlein nephritis, Lancet Lond Engl. 1 févr, vol.339, issue.8788, pp.280-282, 1992.

S. R. Meadow, E. F. Glasgow, R. H. White, M. W. Moncrieff, J. S. Cameron et al., Schönlein-Henoch nephritis, Q J Med. juill, vol.41, issue.163, pp.241-58, 1972.

K. Schärer, R. Krmar, U. Querfeld, H. Ruder, R. Waldherr et al., Clinical outcome of Schönlein-Henoch purpura nephritis in children, Pediatr Nephrol, vol.13, issue.9, pp.816-839, 1999.

J. Ronkainen, M. Ala-houhala, N. P. Huttunen, T. Jahnukainen, O. Koskimies et al., Outcome of Henoch-Schoenlein nephritis with nephrotic-range proteinuria, Clin Nephrol. août, vol.60, issue.2, pp.80-84, 2003.

O. Koskimies, J. Rapola, E. Savilahti, and J. Vilska, Renal involvement in Schönlein-Henoch purpura, Acta Paediatr. mai, vol.63, issue.3, pp.357-63, 1974.

N. Yoshikawa, H. Ito, K. Yoshiya, C. Nakahara, S. Yoshiara et al., Henoch-Schoenlein nephritis and IgA nephropathy in children: a comparison of clinical course, Clin Nephrol. mai, vol.27, issue.5, pp.233-240, 1987.

R. Counahan, M. H. Winterborn, R. H. White, J. M. Heaton, S. R. Meadow et al., Prognosis of Henoch-Schonlein nephritis in children, BMJ. 2 juill, vol.2, issue.6078, pp.11-15, 1977.

P. Niaudet and R. Habib, Schönlein-Henoch purpura nephritis: pronostic factors and therapy, Ann Med Interne (Paris), vol.145, issue.8, pp.577-80, 1994.

R. Coppo, G. Mazzucco, L. Cagnoli, A. Lupo, and F. P. Schena, Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.12, issue.11, pp.2277-83, 1997.

Y. Kawasaki, J. Suzuki, N. Sakai, K. Nemoto, R. Nozawa et al., Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis, Clin Nephrol. sept, vol.60, issue.3, pp.153-60, 2003.

J. Ronkainen, O. Koskimies, M. Ala-houhala, M. Antikainen, J. Merenmies et al., Early prednisone therapy in Henoch-Schönlein purpura: A randomized, double-blind, placebo-controlled trial, J Pediatr. août, vol.149, issue.2, pp.241-248, 2006.

O. Jauhola, J. Ronkainen, O. Koskimies, M. Ala-houhala, P. Arikoski et al., Clinical course of extrarenal symptoms in Henoch-Schonlein purpura: a 6-month prospective study, Arch Dis Child, vol.95, issue.11, pp.871-877, 2010.

R. M. Harper and B. S. Allen, Use of Colchicine in the Treatment of Behçet's Disease, Int J Dermatol, vol.21, issue.9, pp.551-555, 1982.

. Saatçi-Ü, S. Ozen, S. Özdemir, A. Bakkaloglu, N. Besbas et al., Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis, Eur J Pediatr. 25 juill, vol.156, issue.8, pp.619-642, 1997.

J. P. Callen, Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis, J Am Acad Dermatol. août, vol.13, issue.2, pp.193-200, 1985.

D. Pyne, Colchicine for the treatment of recurrent Henoch-Schonlein purpura in an adult, Rheumatology. 1 déc, vol.40, issue.12, pp.1430-1431, 2001.

S. Padeh and J. H. Passwell, Successful treatment of chronic HenochSchonlein purpura with colchicine and aspirin, IMAJ, vol.2, issue.6, pp.482-483, 2000.

N. Mazille, D. Lipsker, and M. Fischbach, Dapsone for chronic skin lesions in 3 children suffering from Henoch-Schönlein vasculitis, Arch Pediatr, issue.18, pp.1201-1205, 2011.

A. P. Bech, L. J. Reichert, C. Tervaert, and J. W. , Dapsone for the treatment of chronic IgA vasculitis (Henoch-Schonlein), Neth J Med. mai, vol.71, issue.4, pp.220-221, 2013.

T. Papandreou, M. Dürken, M. Goebeler, P. H. Hoeger, S. Goerdt et al., Chronic recalcitrant Henoch-Schönlein purpura: successful treatment with dapsone, Eur J Dermatol EJD, vol.20, issue.5, pp.639-679, 2010.

H. Iqbal and A. Evans, Dapsone therapy for Henoch-Schönlein purpura: a case series, Arch Dis Child. sept, vol.90, issue.9, pp.985-991, 2005.

P. F. Weiss, J. A. Feinstein, X. Luan, J. M. Burnham, and C. Feudtner, Effects of Corticosteroid on Henoch-Schonlein Purpura: A Systematic Review. PEDIATRICS, vol.120, issue.5, pp.1079-87, 2007.

N. D. Rosenblum and H. S. Winter, Steroid effects on the course of abdominal pain in children with Henoch-Schonlein purpura, Pediatrics. juin, vol.79, issue.6, pp.1018-1039, 1987.

S. P. Leung, Use of intravenous hydrocortisone in Henoch-Schonlein purpura, J Paediatr Child Health. juin, vol.37, issue.3, pp.309-319, 2001.

D. M. Allen, L. K. Diamond, and D. A. Howell, Anaphylactoid purpura in children (Schonlein-Henoch syndrome): review with a follow-up of the renal complications, AMA J Dis Child. juin, vol.99, pp.833-54, 1960.

I. S. Szer, Gastrointestinal and renal involvement in vasculitis: management strategies in Henoch-Schönlein purpura, Cleve Clin J Med. mai, vol.66, issue.5, pp.312-319, 1999.

T. Lamireau, L. Rebouissoux, and J. Hehunstre, Intravenous immunoglobulin therapy for severe digestive manifestations of Henoch-Schönlein purpura, Acta Paediatr. 2 janv, vol.90, issue.9, pp.1081-1083, 2007.

S. B. Wortmann, T. Fiselier, N. Van-de-kar, R. Aarts, A. Warris et al., Refractory severe intestinal vasculitis due to Henoch-Schönlein Purpura: successful treatment with plasmapheresis, Acta Paediatr. 1 mai, vol.95, issue.5, pp.622-625, 2006.

J. Radhakrishnan and D. C. Cattran, The KDIGO practice guideline on glomerulonephritis: reading between the (guide) lines-application to the individual patient, Kidney Int, vol.82, issue.8, pp.840-856, 2012.

, Henoch-Schönlein purpura nephritis, Kidney Int Suppl. juin, vol.11, issue.2, pp.218-238, 2012.

J. Bergstein, J. Leiser, and S. P. Andreoli, Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy, Clin Nephrol. janv, vol.49, issue.1, pp.9-14, 1998.

P. Tarshish, J. Bernstein, and C. M. Edelmann, Henoch-Schonlein purpura nephritis: course of disease and efficacy of cyclophosphamide, Pediatr Nephrol. 1 janv, vol.19, issue.1, pp.51-57, 2004.

J. I. Shin, J. M. Park, Y. H. Shin, J. H. Kim, J. S. Lee et al., Can azathioprine and steroids alter the progression of severe Henoch-Schönlein nephritis in children?, Pediatr Nephrol. août, vol.20, issue.8, pp.1087-92, 2005.

O. Jauhola, J. Ronkainen, H. Autio-harmainen, O. Koskimies, M. Ala-houhala et al., Cyclosporine A vs. methylprednisolone for Henoch-Schönlein nephritis: a randomized trial, Pediatr Nephrol. déc, vol.26, issue.12, pp.2159-66, 2011.

P. Ren, F. Han, L. Chen, Y. Xu, Y. Wang et al., The Combination of Mycophenolate Mofetil with Corticosteroids Induces Remission of Henoch-Schönlein Purpura Nephritis, Am J Nephrol, vol.36, issue.3, pp.271-278, 2012.

P. Kalliakmani, E. Benou, and D. S. Goumenos, Cyclosporin A in adult patients with Henoch-Schönlein purpura nephritis and nephrotic syndrome; 5 case reports, Clin Nephrol. avr, vol.75, issue.4, pp.380-383, 2011.

E. Pillebout, C. Alberti, L. Guillevin, and A. Ouslimani, Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura, Kidney Int. sept, vol.78, issue.5, pp.495-502, 2010.

F. Maritati, R. Fenoglio, E. Pillebout, E. G. Urban, M. L. Rocco et al., Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein), Arthritis Rheumatol. janv, vol.70, issue.1, pp.109-123, 2018.

M. Hattori, K. Ito, T. Konomoto, H. Kawaguchi, T. Yoshioka et al., Plasmapheresis as the sole therapy for rapidly progressive Henoch-Schönlein purpura nephritis in children, Am J Kidney Dis. mars, vol.33, issue.3, pp.427-460, 1999.

A. Kusuda, K. Migita, M. Tsuboi, M. Degawa, N. Matsuoka et al., Successful treatment of adult-onset Henoch-Schönlein purpura nephritis with high-dose immunoglobulins, Intern Med Tokyo Jpn. avr, vol.38, issue.4, pp.376-385, 1999.

Y. Kawasaki, J. Suzuki, M. Murai, A. Takahashi, M. Isome et al., Plasmapheresis therapy for rapidly progressive Henoch-Schonlein nephritis, Disponible sur, vol.19, 2004.

G. Rostoker, D. Desvaux-belghiti, Y. Pilatte, M. Petit-phar, C. Philippon et al., Immunomodulation with Low-Dose Immunoglobulins for Moderate IgA Nephropathy and Henoch-Schönlein Purpura, Nephron, vol.69, issue.3, pp.327-361, 1995.

A. Sayegh, J. Delapierre, L. Croue, A. Tollis, F. Cousin et al., Addition of Plasma Exchange to Glucocorticosteroids for the Treatment of Severe Henoch-Schönlein Purpura in Adults: A Case Series, Am J Kidney Dis. mai, vol.59, issue.5, pp.663-672, 2012.

A. Audemard-verger, E. Pillebout, L. Guillevin, E. Thervet, and B. Terrier, IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects, Autoimmun Rev. juill, vol.14, issue.7, pp.579-85, 2015.

Y. Ilan and Y. Naparstek, Schönlein-Henoch syndrome in adults and children, Seminars in arthritis and rheumatism, pp.103-109, 1991.

D. Prais, J. Amir, and M. Nussinovitch, Recurrent Henoch-Schönlein purpura in children, J Clin Rheumatol, vol.13, issue.1, pp.25-28, 2007.

J. I. Shin, J. M. Park, Y. H. Shin, D. H. Hwang, J. H. Kim et al., Predictive factors for nephritis, relapse, and significant proteinuria in childhood Henoch-Schönlein purpura, Scand J Rheumatol. janv, vol.35, issue.1, pp.56-60, 2006.

A. Audemard-verger, B. Terrier, A. Dechartres, J. Chanal, Z. Amoura et al., Characteristics and Management of IgA Vasculitis (Henoch-Schönlein) in Adults: Data From 260 Patients Included in a French Multicenter Retrospective Survey: IgA VASCULITIS IN ADULTS, Arthritis Rheumatol. sept, vol.69, issue.9, pp.1862-70, 2017.

M. Daroux, C. Gaxatte, F. Puisieux, B. Corman, and É. Boulanger, Vieillissement rénal : facteurs de risque et néphroprotection. Presse Médicale, vol.38, pp.1667-79, 2009.

R. F. Ritchie, G. E. Palomaki, L. M. Neveux, O. Navolotskaia, T. B. Ledue et al., Reference distributions for immunoglobulins A, G, and M: a practical, simple, and clinically relevant approach in a large cohort, J Clin Lab Anal, vol.12, issue.6, pp.363-370, 1998.

R. F. Ritchie, G. E. Palomaki, L. M. Neveux, and O. Navolotskaia, Reference distributions for immunoglobulins A, G, and M: a comparison of a large cohort to the world's literature, J Clin Lab Anal, vol.12, issue.6, pp.371-377, 1998.

F. Listi, G. Candore, M. A. Modica, M. Russo, G. D. Lorenzo et al., A Study of Serum Immunoglobulin Levels in Elderly Persons That Provides New Insights into B Cell Immunosenescence, Ann N Y Acad Sci, vol.1089, issue.1, pp.487-95, 2006.

R. J. Lock and D. J. Unsworth, Immunoglobulins and immunoglobulin subclasses in the elderly, Ann Clin Biochem, vol.40, issue.2, pp.143-148, 2003.

R. A. Black, S. R. Kronheim, M. Cantrell, M. C. Deeley, C. J. March et al., Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor, J Biol Chem. 5 juill, vol.263, issue.19, pp.9437-9479, 1988.

N. A. Thornberry, H. G. Bull, J. R. Calaycay, K. T. Chapman, A. D. Howard et al., A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes, Nature. 30 avr, vol.356, issue.6372, pp.768-74, 1992.

H. M. Hoffman and S. D. Brydges, Genetic and molecular basis of inflammasome-mediated disease, J Biol Chem. 1 avr, vol.286, issue.13, pp.10889-96, 2011.

C. Gabay, C. Lamacchia, and G. Palmer, IL-1 pathways in inflammation and human diseases, Nat Rev Rheumatol. avr, vol.6, issue.4, pp.232-273, 2010.

C. A. Dinarello, T. Ikejima, S. J. Warner, S. F. Orencole, G. Lonnemann et al., Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro, J Immunol Baltim Md, vol.139, issue.6, pp.1902-1912, 1950.

C. A. Dinarello and J. Van-der-meer, Treating inflammation by blocking interleukin-1 in humans, Semin Immunol. déc, vol.25, issue.6, pp.469-84, 2013.

M. Braddock and A. Quinn, Targeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention, Nat Rev Drug Discov. avr, vol.3, issue.4, pp.330-370, 2004.

J. Satsangi, R. A. Wolstencroft, J. Cason, C. C. Ainley, D. C. Dumonde et al., Interleukin 1 in Crohn's disease, Clin Exp Immunol. mars, vol.67, issue.3, pp.594-605, 1987.

Y. R. Mahida, K. Wu, and D. P. Jewell, Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease, Gut. 1 juin, vol.30, issue.6, pp.835-843, 1989.

M. Ligumsky, P. L. Simon, F. Karmeli, and D. Rachmilewitz, Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease, Gut. 1 juin, vol.31, issue.6, pp.686-695, 1990.

H. Reinecker, M. Steffen, T. Witthoeft, I. Pflueger, S. Schreiber et al., Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1? by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease, Clin Exp Immunol. 28 juin, vol.94, issue.1, pp.174-81, 2008.

M. E. Mcalindon, C. J. Hawkey, and Y. R. Mahida, Expression of interleukin 1beta and interleukin 1beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease, Gut. 1 févr, vol.42, issue.2, pp.214-223, 1998.

V. Casini-raggi, L. Kam, Y. J. Chong, C. Fiocchi, T. T. Pizarro et al., Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation, J Immunol Baltim Md 1950. 1 mars, vol.154, issue.5, pp.2434-2474, 1995.

O. Ludwiczek, E. Vannier, I. Borggraefe, A. Kaser, B. Siegmund et al., Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease, Clin Exp Immunol, vol.138, issue.2, pp.323-332, 2004.

F. Cominelli, C. C. Nast, B. D. Clark, R. Schindler, R. Lierena et al., Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis, J Clin Invest. 1 sept, vol.86, issue.3, pp.972-80, 1990.

I. Okayasu, S. Hatakeyama, M. Yamada, T. Ohkusa, Y. Inagaki et al., A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice, Gastroenterology. mars, vol.98, issue.3, pp.694-702, 1990.

R. D. Mccall, S. Haskill, E. M. Zimmermann, P. K. Lund, R. C. Thompson et al., Tissue interleukin 1 and interleukin-1 receptor antagonist expression in enterocolitis in resistant and susceptible rats, Gastroenterology, vol.106, issue.4, pp.960-972, 1994.

T. K. Thomas, P. C. Will, A. Srivastava, C. L. Wilson, M. Harbison et al., Evaluation of an interleukin-1 receptor antagonist in the rat acetic acid-induced colitis model, Agents Actions. sept, vol.34, issue.1-2, pp.187-90, 1991.

F. Cominelli, C. C. Nast, A. Duchini, and M. Lee, Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis, Gastroenterology. juill, vol.103, issue.1, pp.65-71, 1992.

B. Siegmund, H. Lehr, G. Fantuzzi, and C. A. Dinarello, IL-1 -converting enzyme (caspase-1) in intestinal inflammation, Proc Natl Acad Sci, vol.98, issue.23, pp.13249-54, 2001.

A. J. Müller, C. Hoffmann, M. Galle, A. Van-den-broeke, M. Heikenwalder et al., The S. Typhimurium Effector SopE Induces Caspase-1 Activation in Stromal Cells to Initiate Gut Inflammation, Cell Host Microbe. août, vol.6, issue.2, pp.125-161, 2009.

J. Ng, S. A. Hirota, O. Gross, Y. Li, A. Ulke-lemee et al., Clostridium difficile Toxin-Induced Inflammation and Intestinal Injury Are Mediated by the Inflammasome, Gastroenterology. août, vol.139, issue.2, pp.542-552, 2010.

M. Coccia, O. J. Harrison, C. Schiering, M. J. Asquith, B. Becher et al., IL-1? mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4 + Th17 cells, J Exp Med, vol.209, issue.9, pp.1595-609, 2012.

, Chapitre 10 Détection/dosage des cytokines et de leurs récepteurs, Méthodes en immunologie, 2014.

J. Bienvenu, G. Monneret, N. Fabien, and M. Gutowski, Les cytokines : Méthodes d'exploration et intérêt clinique, Rev Fr Lab. déc, issue.328, pp.37-46, 2000.

F. Chowdhury, A. Williams, and P. Johnson, Validation and comparison of two multiplex technologies, Luminex® and Mesoscale Discovery, for human cytokine profiling, J Immunol Methods. janv, vol.340, issue.1, pp.55-64, 2009.

J. A. Bastarache, T. Koyama, N. E. Wickersham, and L. B. Ware, Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples, J Immunol Methods. juin, vol.408, pp.13-23, 2014.

J. Dayer, The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis, Rheumatology. 1 mai, vol.42, issue.90002, pp.3-10, 2003.

M. B. Goldring, E. Sohbat, J. M. Elwell, and J. Y. Chang, Etodolac preserves cartilage-specific phenotype in human chondrocytes: effects on type II collagen synthesis and associated mRNA levels, Eur J Rheumatol Inflamm, vol.10, issue.1, pp.10-21, 1990.

M. B. Goldring, L. Suen, R. Yamin, and W. Lai, Regulation of Collagen Gene Expression by Prostaglandins and Interleukin-1beta in Cultured Chondrocytes and Fibroblasts, Am J Ther. janv, vol.3, issue.1, pp.9-16, 1996.

M. Cao, A. Westerhausen-larson, C. Niyibizi, K. Kavalkovich, H. I. Georgescu et al., Nitric oxide inhibits the synthesis of type-II collagen without altering Col2A1 mRNA abundance: prolyl hydroxylase as a possible target, Biochem J. 15 mai, vol.324, pp.305-315, 1997.

H. J. Häuselmann, L. Oppliger, B. A. Michel, M. Stefanovic-racic, and C. H. Evans, Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate culture, FEBS Lett, vol.352, issue.3, pp.361-365, 1994.

D. Taskiran, M. Stefanovic-racic, H. Georgescu, and C. Evans, Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1, Biochem Biophys Res Commun. 15 avr, vol.200, issue.1, pp.142-150, 1994.

F. J. Blanco, R. L. Ochs, H. Schwarz, and M. Lotz, Chondrocyte apoptosis induced by nitric oxide, Am J Pathol. janv, vol.146, issue.1, pp.75-85, 1995.

R. M. Clancy, A. R. Amin, and S. B. Abramson, The role of nitric oxide in inflammation and immunity, Arthritis Rheum. juill, vol.41, issue.7, pp.1141-51, 1998.

K. Sasaki, T. Hattori, T. Fujisawa, K. Takahashi, H. Inoue et al., Nitric oxide mediates interleukin-1-induced gene expression of matrix metalloproteinases and basic fibroblast growth factor in cultured rabbit articular chondrocytes, J Biochem (Tokyo). mars, vol.123, issue.3, pp.431-440, 1998.

E. Maneiro, M. J. López-armada, J. L. Fernández-sueiro, B. Lema, F. Galdo et al., Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes, J Rheumatol. déc, vol.28, issue.12, pp.2692-2701, 2001.

J. P. Pelletier, F. Mineau, P. Ranger, G. Tardif, and J. Martel-pelletier, The increased synthesis of inducible nitric oxide inhibits IL-1ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation, Osteoarthritis Cartilage. mars, vol.4, issue.1, pp.77-84, 1996.

A. A. Van-de-loo, O. J. Arntz, A. C. Bakker, P. L. Van-lent, M. J. Jacobs et al., Role of interleukin 1 in antigen-induced exacerbations of murine arthritis, Am J Pathol. janv, vol.146, issue.1, pp.239-288, 1995.

P. L. Van-lent, F. A. Van-de-loo, A. E. Holthuysen, L. A. Van-den-bersselaar, H. Vermeer et al., Major role for interleukin 1 but not for tumor necrosis factor in early cartilage damage in immune complex arthritis in mice, J Rheumatol. déc, vol.22, issue.12, pp.2250-2258, 1995.

B. Henderson and E. R. Pettipher, Arthritogenic actions of recombinant IL-1 and tumour necrosis factor alpha in the rabbit: evidence for synergistic interactions between cytokines in vivo, Clin Exp Immunol. févr, vol.75, issue.2, pp.306-316, 1989.

S. C. Ghivizzani, E. R. Lechman, C. Tio, K. M. Mulé, S. Chada et al., Direct retrovirus-mediated gene transfer to the synovium of the rabbit knee: implications for arthritis gene therapy, Gene Ther. sept, vol.4, issue.9, pp.977-82, 1997.

E. C. Arner, R. R. Harris, T. M. Dimeo, R. C. Collins, and W. Galbraith, Interleukin-1 receptor antagonist inhibits proteoglycan breakdown in antigen induced but not polycation induced arthritis in the rabbit, J Rheumatol. juill, vol.22, issue.7, pp.1338-1384, 1995.

L. A. Joosten, M. M. Helsen, F. A. Van-de-loo, and W. B. Van-den-berg, Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra, Arthritis Rheum. mai, vol.39, issue.5, pp.797-809, 1996.

L. A. Joosten, M. M. Helsen, T. Saxne, F. A. Van-de-loo, D. Heinegard et al., IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation, J Immunol Baltim Md, vol.163, issue.9, pp.5049-55, 1950.

G. Bandara, G. M. Mueller, J. Galea-lauri, M. H. Tindal, H. I. Georgescu et al., Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer, Proc Natl Acad Sci, vol.90, issue.22, pp.10764-10772, 1993.

G. L. Hung, J. Galea-lauri, G. M. Mueller, H. I. Georgescu, L. A. Larkin et al., Suppression of intra-articular responses to interleukin-1 by transfer of the interleukin-1 receptor antagonist gene to synovium, Gene Ther. janv, vol.1, issue.1, pp.64-73, 1994.

B. J. Roessler, J. W. Hartman, D. K. Vallance, J. M. Latta, S. L. Janich et al., Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector, Hum Gene Ther. mars, vol.6, issue.3, pp.307-323, 1995.

A. R. Pettit, J. H. , V. Stechow, D. Müller, R. Goldring et al., TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis, Am J Pathol, vol.159, issue.5, pp.1689-1699, 2001.

S. B. Cohen, L. W. Moreland, J. J. Cush, M. W. Greenwald, S. Block et al., A multicentre, double blind, randomised, placebo controlled trial of anakinra (Kineret), a recombinant interleukin 1 receptor antagonist, in patients with rheumatoid arthritis treated with background methotrexate, Ann Rheum Dis. sept, vol.63, issue.9, pp.1062-1070, 2004.

S. Nikfar, P. Saiyarsarai, B. M. Tigabu, and M. Abdollahi, Efficacy and safety of interleukin-1 antagonists in rheumatoid arthritis: a systematic review and meta-analysis, Rheumatol Int. août, vol.38, issue.8, pp.1363-83, 2018.

D. Mcgonagle, A. L. Tan, J. Madden, P. Emery, and M. F. Mcdermott, Successful treatment of resistant pseudogout with anakinra, Arthritis Rheum. févr, vol.58, issue.2, pp.631-634, 2008.

L. D. Church, G. P. Cook, and M. F. Mcdermott, Primer: inflammasomes and interleukin 1? in inflammatory disorders, Nat Clin Pract Rheumatol. janv, vol.4, issue.1, pp.34-42, 2008.

V. Pascual, F. Allantaz, E. Arce, M. Punaro, and J. Banchereau, Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade, J Exp Med. 2 mai, vol.201, issue.9, pp.1479-86, 2005.

P. Quartier, F. Allantaz, R. Cimaz, P. Pillet, C. Messiaen et al., A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial), Ann Rheum Dis. 1 mai, vol.70, issue.5, pp.747-54, 2011.

A. A. Fitzgerald, S. A. Leclercq, A. Yan, J. E. Homik, and C. A. Dinarello, Rapid responses to anakinra in patients with refractory adult-onset Still's disease, Arthritis Rheum. juin, vol.52, issue.6, pp.1794-803, 2005.

G. D. Kalliolias, P. E. Georgiou, I. A. Antonopoulos, A. P. Andonopoulos, and S. Liossis, Anakinra treatment in patients with adult-onset Still's disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial, Ann Rheum Dis. juin, vol.66, issue.6, pp.842-845, 2007.

B. Ostendorf, C. Iking-konert, K. Kurz, G. Jung, O. Sander et al., Preliminary results of safety and efficacy of the interleukin 1 receptor antagonist anakinra in patients with severe lupus arthritis, Ann Rheum Dis. avr, vol.64, issue.4, pp.630-633, 2005.

. Vii, Annexes La version éditeur de l'article mis en annexe dans la version papier ne peut être diffusée. C'est la version open access qui est ici référencée avec un accès au texte intégral avec le DOI